×
Instil Bio Inc
7.73 0.04  (0.52 %)
↓ 77.15% Fall from 52W High
  • ABOUT
  • CORPORATE ACTIONS
  • INSIDER TRADING
  • CHECKLIST
  • OWNERSHIP
  • TECHNICALS
  • FINANCIALS
  • SWOT
  • OVERVIEW
TECHNICALS OWNERSHIP CHECKLIST DEALS CORPORATE ACTIONS ABOUT
Strengths 8
Weakness 8
Opportunity 2
Threats 2
  • Strengths
  • Weakness
  • Opportunity
  • Threats
  • Significant (over 30%) distance from 52 week high
  • Annual Profit Growth higher than Sector Profit Growth
  • PEG lower than Industry PEG
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Annual Net Profits improving for last 2 years
  • Increasing profits every quarter for the past 4 quarters
  • Top Gainers
  • Stock with Low PE (PE < = 10)
  • Stocks with Quarter Change % less than Industry
  • Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
  • Stocks with Expensive Valuations according to the Trendlyne Valuation Score
  • Highest fall from 52 Week High
  • Low Piotroski Score : Companies with weak financials
  • Declining Net Cash Flow : Companies not able to generate net cash
  • Book Value Per Share deteriorating for last 2 years
  • Stocks Underperforming their Industry Price Change in the Quarter
  • Companies with Upcoming Results
  • Institutions increasing their shareholding
  • Mutual Funds Decreased Shareholding in Past Month
  • MFs decreased their shareholding last quarter
Note: Financial Information is based on numbers.
Market Capitalization
Low in industry
52.4
PE TTM
Negative PE TTM
-1.1
PEG TTM
Negative PEG TTM
0
Price to Book
Low in industry
0.5
Operating Profit Margin Qtr %
 
-
Dividend yield 1yr %
 
0
Oper Rev Qtr
 
0
Net Profit Qtr
85.1% incr over last year
-4.2
Operating Profit Qtr
58.4% incr over last year
-6.0
Operating Revenue TTM
 
0
Net profit TTM
39.3% incr over last year
-47.4
Basic EPS TTM
39.3% incr over last year
-7.0
RSI
RSI is mid-range
46.9
MFI
MFI is mid-range
36.1
PAST EVENT  •  Jun 11, 2026
Board Meeting - Instil Bio Inc Annual General Meeting for 2026
The latest board meeting for Instil Bio Inc took place on Jun 11, 2026, for the purpose of Instil Bio Inc Annual General Meeting for 2026 .

*All Financial parameters are in Million USD.

Instil Bio Inc EMA & SMA

7.73 ↑ 0.52%
CURRENT PRICE
Bullish Moving Averages
Bearish Moving Averages
5 Day 7.7
10 Day 7.7
12 Day 7.7
20 Day 7.7
26 Day 7.8
50 Day 8.0
100 Day 8.7
200 Day 11.2
5 Day 7.6
10 Day 7.6
20 Day 7.8
30 Day 7.9
50 Day 7.9
100 Day 8.2
150 Day 8.6
200 Day 10.8

Instil Bio Inc DELIVERY AND VOLUME

LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator

Instil Bio Inc RESISTANCE AND SUPPORT

7.80
PIVOT
First Resistance 7.9
Second Resistance 8.1
Third Resistance 8.2
First Support 7.6
Second Support 7.5
Third Support 7.3
Day RSI 46.9
Day MACD -0.1
Day MFI 36.1
Day MACD Signal Line -0.1
+ MORE
Day ADX 15.6
Day ATR 0.3
Day Commodity Channel Index 2.2
Day ROC125 -29.7
Day ROC21 -4.7
William -48.0
- LESS

Instil Bio Inc BETA

1 Month 0.2
1 Year 0.2
3 Months 0.1
3 Years 0.3

Instil Bio Inc PRICE CHANGE ANALYSIS

↓ -6.1%
Over 1 Month
Low High
7.4 8.3
↓ -3.7%
Over 3 Months
Low High
7.4 9
↓ -31.4%
Over 6 Months
Low High
5.7 12.9
↓ -71.9%
Over 1 Year
Low High
5.7 33.8
View full Share Price History/Seasonality
Powered by Source: trendlyne.com
Client Name Client Category Action Reported to Exchange Quantity Avg. Price Value Security Type
GEORGE MATCHAM Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2026 6,500 Stock Option (Right to Buy)
R. KENT MCGAUGHY Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2026 6,500 Stock Option (Right to Buy)
GWENDOLYN K. BINDER Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2026 6,500 Stock Option (Right to Buy)
SANDEEP LAUMAS CFO and CBO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Sep 2025 17,000 Employee Stock Option (right to buy)
SANDEEP LAUMAS CFO and CBO Sale of securities on an exchange or to another person at price $ 23.88 per share. 10 Sep 2025 12,461 23.9 297,569.00 Common Stock
SANDEEP LAUMAS CFO and CBO Sale of securities on an exchange or to another person at price $ 23.04 per share. 10 Sep 2025 17,539 23.0 404,099.00 Common Stock
SANDEEP LAUMAS CFO and CBO Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.68 per share. 10 Sep 2025 13,000 12.7 164,840.00 Common Stock
SANDEEP LAUMAS CFO and CBO Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.60 per share. 10 Sep 2025 17,000 11.6 197,200.00 Common Stock
SANDEEP LAUMAS CFO and CBO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Sep 2025 13,000 Employee Stock Option (right to buy)
GEORGE MATCHAM Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2025 6,500 Stock Option (Right to Buy)
R. KENT MCGAUGHY Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2025 6,500 Stock Option (Right to Buy)
GWENDOLYN K. BINDER Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2025 6,500 Stock Option (Right to Buy)
NEIL GIBSON Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2025 6,500 Stock Option (Right to Buy)
SANDEEP LAUMAS CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2025 44,851 Employee Stock Option (right to buy)
BRONSON CROUCH Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2025 105,157 Employee Stock Option (right to buy)
BRONSON CROUCH Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2024 50,000 Employee Stock Option (right to buy)
SANDEEP LAUMAS CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2024 45,000 Employee Stock Option (right to buy)
NEIL GIBSON Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,000 Stock Option (Right to Buy)
R. KENT MCGAUGHY Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,000 Stock Option (Right to Buy)
GWENDOLYN K. BINDER-SCHOLL Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,000 Stock Option (Right to Buy)
GEORGE MATCHAM Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,000 Stock Option (Right to Buy)
BRONSON CROUCH Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2024 120,000 Employee Stock Option (right to buy)
LAUMAS SANDEEP CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2024 80,000 Employee Stock Option (right to buy)
BINDER-SCHOLL GWENDOLYN Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 1,500 Stock Option (Right to Buy)
MATCHAM GEORGE Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 1,500 Stock Option (Right to Buy)
GIBSON NEIL Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 1,500 Stock Option (Right to Buy)
NIELSEN JACK BECH Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 1,500 Stock Option (Right to Buy)
MCGAUGHY R. KENT Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 1,500 Stock Option (Right to Buy)
SUMITA RAY Chief Legal and Admin Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2023 415,000 Employee Stock Option (right to buy)
RAY SUMITA Chief Legal and Admin Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2023 50,000 Employee Stock Option (right to buy)
CROUCH BRONSON Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2023 1,000,000 Employee Stock Option (right to buy)
LAUMAS SANDEEP CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2023 415,000 Employee Stock Option (right to buy)
TIMOTHY L. MOORE Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Sep 2022 750,000 Employee Stock Option (right to buy)
GEORGE MATCHAM Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 30,000 Employee Stock Option (right to buy)
VIJAY CHIRUVOLU Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 154,237 Employee Stock Option (right to buy)
R. KENT MCGAUGHY Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 30,000 Employee Stock Option (right to buy)
GWENDOLYN BINDER-SCHOLL Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 30,000 Employee Stock Option (right to buy)
JACK BECH NIELSEN Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 30,000 Employee Stock Option (right to buy)
NEIL GIBSON Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 30,000 Employee Stock Option (right to buy)
R. KENT MCGAUGHY Director Other type of transaction at price $ 0.00 per share. 15 Mar 2022 260,323 Common Stock
VIJAY CHIRUVOLU Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2022 257,000 Employee Stock Option (right to buy)
ZACHARY ROBERTS Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2022 245,000 Employee Stock Option (right to buy)
BRONSON CROUCH Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2022 750,000 Employee Stock Option (right to buy)
SANDEEP LAUMAS CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2022 234,000 Employee Stock Option (right to buy)
ZACHARY ROBERTS Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2021 120,000 Employee Stock Option (right to buy)
ZACHARY ROBERTS Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Sep 2021 120,000 Employee Stock Option (right to buy)
SANDEEP LAUMAS CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 200,000 Employee Stock Option (right to buy)
BRONSON CROUCH Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 750,000 Employee Stock Option (right to buy)
ZACHARY ROBERTS Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 200,000 Employee Stock Option (right to buy)
VIJAY CHIRUVOLU Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 200,000 Employee Stock Option (right to buy)
Security Type:  Share/ Warrants / Convertible Debentures
Client Category:  Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Data as reported to USA Exchanges
  • Split
  • Board Meetings
Ex-Date Old FV New FV Record Date
08 Dec, 2023 1 20
Ex-Date Purpose Notes
11 Jun, 2027 Instil Bio Inc Annual General Meeting for 2027 None
14 May, 2027 Instil Bio Inc First Quarter Earnings Results for 2027 None
26 Mar, 2027 Instil Bio Inc Annual Report for 2026 None
26 Mar, 2027 Instil Bio Inc Fourth Quarter Earnings Results for 2026 None
13 Nov, 2026 Instil Bio Inc Third Quarter Earnings Results for 2026 None
13 Aug, 2026 Instil Bio Inc Second Quarter Earnings Results for 2026 None
11 Jun, 2026 Instil Bio Inc Annual General Meeting for 2026 None
28 May, 2026 Instil Bio Inc Annual General Meeting for 2026 None
20 May, 2026 Instil Bio Inc First Quarter Earnings Results for 2026 None
15 May, 2026 Instil Bio Inc First Quarter Earnings Results for 2026 None
Powered by Source: trendlyne.com